US Patent 7595389 siRNA targeting casitas B cell lymphoma-B (CBL-B)
Patent 7595389 was granted and assigned to Dharmacon, Inc. on September, 2009 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 23, 2007
Date of Patent
September 29, 2009
Patent Application Number
11880628
Patent Inventor Names
William Marshall
0
Devin Leake
0
Stephen Scaringe
0
Steven Read
0
Anastasia Khvorova
0
Angela Reynolds
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7595389 siRNA targeting casitas B cell lymphoma-B (CBL-B)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.